Sou Hu Cai Jing·2025-10-15 09:47Core Insights - The CSI Medical Index (399989) closed at 7552.84 points, up 1.42%, with a trading volume of 20.99 billion yuan and a turnover rate of 1.72% [1] - Among the index constituents, 40 stocks rose, with Jiuzhou Pharmaceutical leading at a 6.04% increase, while 10 stocks fell, with BGI Genomics leading the decline at 2.93% [1] Index Constituents Summary - The top ten constituents of the CSI Medical Index include: - WuXi AppTec (603259) with a weight of 14.78%, latest price at 99.46, and a 3.69% increase [1] - Mindray Medical (300760) with a weight of 8.91%, latest price at 230.50, and a slight decrease of 0.08% [1] - United Imaging Healthcare (688271) with a weight of 8.15%, latest price at 148.36, and a 0.38% increase [1] - Aier Eye Hospital (300015) with a weight of 6.25%, latest price at 12.68, and a 0.16% increase [1] - Kanglong Chemical (300759) with a weight of 3.44%, latest price at 31.35, and a 4.33% increase [1] - Tigermed (300347) with a weight of 3.26%, latest price at 55.07, and a 2.51% increase [1] - Aimeike (300896) with a weight of 2.98%, latest price at 175.15, and a slight decrease of 0.19% [1] - New Industry (300832) with a weight of 2.92%, latest price at 62.62, and a decrease of 0.98% [1] - Huatai Medical (688617) with a weight of 2.91%, latest price at 311.26, and a slight decrease of 0.08% [1] - Yuyue Medical (002223) with a weight of 2.55%, latest price at 38.00, and a 0.66% increase [1] Capital Flow Analysis - The CSI Medical Index constituents experienced a net inflow of 397 million yuan from institutional investors, while retail investors saw a net outflow of 204 million yuan [3] - Key stocks with significant capital flow include: - Meinian Health (002044) with a net inflow of 88.56 million yuan from institutional investors [3] - Aier Eye Hospital (300015) with a net inflow of 81.55 million yuan from institutional investors [3] - Mindray Medical (300760) with a net inflow of 79.59 million yuan from institutional investors [3] - Jiuzhou Pharmaceutical (603456) with a net inflow of 62.91 million yuan from institutional investors [3] - Huatai Medical (688617) with a net inflow of 28.38 million yuan from institutional investors [3]